Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
83,427 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Tildrakizumab (Ilumya)PayerPolicy · BCBSNJ-DRUGS-179-F21120282F | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Arsenic Trioxide (Trisenox)PayerPolicy · BCBSNJ-DRUGS-177-B3FBA7716F | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Radiation Treatment with Lutathera (Lutetium; Lu 177 dotatate)PayerPolicy · BCBSNJ-DRUGS-176-50647742B2 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Voretigene neparvovec-rzyl (Luxturna)PayerPolicy · BCBSNJ-DRUGS-165-3AD73FAA5D | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Axicabtagene Ciloleucel (Yescarta)PayerPolicy · BCBSNJ-DRUGS-164-D00B1DEDA3 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Copanlisib (Aliqopa)PayerPolicy · BCBSNJ-DRUGS-163-E84C3A8B0D | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Gemtuzumab Ozogamicin (Mylotarg)PayerPolicy · BCBSNJ-DRUGS-162-BBBC3A9B12 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Liposomal Formulation of Daunorubicin and Cytarabine (Vyxeos)PayerPolicy · BCBSNJ-DRUGS-161-711D747DE6 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Inotuzumab Ozogamicin (Besponsa)PayerPolicy · BCBSNJ-DRUGS-160-912BF20078 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Belinostat (Beleodaq)PayerPolicy · BCBSNJ-DRUGS-159-F54A453407 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Tisagenlecleucel (Kymriah)PayerPolicy · BCBSNJ-DRUGS-158-DD09970816 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Edaravone (Radicava)PayerPolicy · BCBSNJ-DRUGS-156-CCDD6F6F95 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Durvalumab (Imfinzi)PayerPolicy · BCBSNJ-DRUGS-155-AB4ECF3581 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Dupilumab (Dupixent)PayerPolicy · BCBSNJ-DRUGS-153-3242E579E6 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Avelumab (Bavencio)PayerPolicy · BCBSNJ-DRUGS-152-56E55DCC03 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Cerliponase Alfa (Brineura)PayerPolicy · BCBSNJ-DRUGS-151-58A16BAAE2 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Ocrelizumab (Ocrevus)PayerPolicy · BCBSNJ-DRUGS-150-32F9539D1A | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Etelcalcetide (Parsabiv)PayerPolicy · BCBSNJ-DRUGS-149-78FD8FE54C | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Nusinersen (Spinraza)PayerPolicy · BCBSNJ-DRUGS-147-30F54B06CB | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Probuphine (Buprenorphine) Implant for Subdermal Administration and Sublocade (Buprenorphine Extended-Release) Injection for Subcutaneous UsePayerPolicy · BCBSNJ-DRUGS-145-189E498D85 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Olaratumab (Lartruvo)PayerPolicy · BCBSNJ-DRUGS-144-18629AE4CB | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Eteplirsen (Exondys 51), Golodirsen (Vyondys 53), Viltolarsen (Viltepso) for Duchenne Muscular DystrophyPayerPolicy · BCBSNJ-DRUGS-143-D8DB8787B2 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Site of Service for Administration for Infusion and Injectable Prescription MedicationsPayerPolicy · BCBSNJ-DRUGS-142-64A49265AA | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Drug Therapy for Transgender PolicyPayerPolicy · BCBSNJ-DRUGS-141-E31821BDEB | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Atezolizumab (Tecentriq)PayerPolicy · BCBSNJ-DRUGS-140-27A88AD742 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Fulvestrant (Faslodex)PayerPolicy · BCBSNJ-DRUGS-138-B6A45FA175 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Melphalan (Alkeran and Evomela)PayerPolicy · BCBSNJ-DRUGS-137-E12C5A79AF | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Sebelipase alfa (Kanuma)PayerPolicy · BCBSNJ-DRUGS-136-8247B93354 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Daratumumab (Darzalex), Daratumumab and hyaluronidase-fihj (Darzalex Faspro)PayerPolicy · BCBSNJ-DRUGS-135-226C88A221 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Elotuzumab (Empliciti)PayerPolicy · BCBSNJ-DRUGS-134-975447F337 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Monoclonal Interleukin-5 Antagonists [mepolizumab (Nucala), reslizumab (Cinqair), and benralizumab (Fasenra)]PayerPolicy · BCBSNJ-DRUGS-133-2ADC519856 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Compounded Medications and Compounding KitsPayerPolicy · BCBSNJ-DRUGS-129-80EB4619D1 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Lemtrada (Alemtuzumab)PayerPolicy · BCBSNJ-DRUGS-127-9B8A5CDC04 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Blinatumomab (Blincyto)PayerPolicy · BCBSNJ-DRUGS-126-DAD4FB2474 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Nivolumab (Opdivo)PayerPolicy · BCBSNJ-DRUGS-125-ED9CBE5AAA | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Pembrolizumab (Keytruda)PayerPolicy · BCBSNJ-DRUGS-124-B81D0CE356 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Levoleucovorin (Fusilev and Khapzory)PayerPolicy · BCBSNJ-DRUGS-122-16CFD1DF59 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Vedolizumab (Entyvio)PayerPolicy · BCBSNJ-DRUGS-121-DECB2B279B | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Female Hormones (Non-Oral Hormonal Contraceptives, Oral Contraceptives, Implantable Estrogens)PayerPolicy · BCBSNJ-DRUGS-120-9C02C6381C | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Siltuximab (Sylvant)PayerPolicy · BCBSNJ-DRUGS-119-DE19AA24C1 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Sandostatin, Sandostatin LAR depot (Octreotide), Somatuline Depo (lanreotide), Signifor LAR (pasireotide)PayerPolicy · BCBSNJ-DRUGS-118-6096E061EB | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Bortezomib (Velcade)PayerPolicy · BCBSNJ-DRUGS-117-4C26E16E4D | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Bendamustine Hydrochloride (Treanda, Bendeka, Belrapzo)PayerPolicy · BCBSNJ-DRUGS-116-EFD9F530EC | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Gazyva (Obinutuzumab)PayerPolicy · BCBSNJ-DRUGS-115-71C22348AD | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Ocriplasmin (Jetrea)PayerPolicy · BCBSNJ-DRUGS-110-E55418FC6B | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Omacetaxine Mepesuccinate (Synribo)PayerPolicy · BCBSNJ-DRUGS-106-6B01B31E96 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Marqibo (Vincristine Sulfate Liposome Injection)PayerPolicy · BCBSNJ-DRUGS-103-9082A872D8 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Carfilzomib (Kyprolis)PayerPolicy · BCBSNJ-DRUGS-102-8C23399B10 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Erwinaze (Asparaginase Erwinia Chrysanthemi), Oncaspar (pegaspargase) and Asparlas (calaspargase pegol-mknl)PayerPolicy · BCBSNJ-DRUGS-100-DF31757ABC | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Solesta (Dextranomer and Sodium Hyaluronate Gel for Submucosal Injection)PayerPolicy · BCBSNJ-TREATMENT-137-1BBB5272C4 | New policy |
|---|